4-Hydroxybenzylamine | CAS:696-60-6

We serve 4-Hydroxybenzylamine CAS:696-60-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Hydroxybenzylamine

Chemical Name:4-Hydroxybenzylamine
CAS.NO:696-60-6
Synonyms:4-Hydroxybenzylamine
4-(aminomethyl)phenol
para-Hydroxybenzylamine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 262.4±15.0 °C at 760 mmHg
Melting Point 116-118ºC
Molecular Formula C7H9NO
Molecular Weight 123.152
Flash Point 112.5±20.4 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.594
 
Specification:
Appearance:Brown-yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Itopride(CAS:122898-67-3).



Contact us for information like 4-Hydroxybenzylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,para-Hydroxybenzylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,para-Hydroxybenzylamine Use and application,4-Hydroxybenzylamine technical grade,usp/ep/jp grade.


Related News: With the death toll surging past 300 and 14,300 cases confirmed, authorities across the country have activated the highest public health emergency response, stepping up screening of arrivals from Wuhan.4-Fluoro-2-methoxy-5-nitroaniline manufacturer In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.Methoxyammonium chloride supplier In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.ethyl isocyanate vendor Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.“Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.